Login to Your Account

South Korea's Yuhan looks to raise global profile in Sorrento deal

By Haky Moon
Staff Writer

Thursday, April 7, 2016

HONG KONG – South Korea's oldest and most respected pharmaceutical company, Yuhan Co. Ltd., is looking to move more aggressively into the global biopharma scene by striking up partnerships with U.S.-based companies that have larger global presences.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription